Streetbeat News

Equity Actions

LRMR

Larimar Therapeutics has announced the pricing of its public offering of 17.16 million shares at $8.74 per share, aiming to raise approximately $150 million in gross proceeds.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 11:18 am

LRMR

Larimar Therapeutics has terminated its sales agreement with Guggenheim Securities, which was initially entered into on November 10, 2022. This agreement allowed Larimar Therapeutics to offer and sell shares up to $50 million.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 11:12 am

ACAC

Acri Capital Acquisition has announced an extension of its deadline to complete an initial business combination, now set for March 14, 2024. This extension provides the company with additional time to find and finalize a merger or acquisition deal.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 11:10 am

GOLD

Barrick Gold's Board of Directors has authorized a new share buyback program allowing for the repurchase of up to $1 billion of its common shares over the next 12 months. This new program replaces the one announced on February 15, 2023, under which no shares were repurchased. Previously, Barrick repurchased $424 million in common shares under its 2022 program.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 11:05 am

BABA

BIDU

CNYA

EWH

JD

TCEHY

Emerging markets fund manager Mark Mobius sees investment opportunities in the underperforming Chinese and Hong Kong markets, comparing them favorably to India's recent success. He highlights criteria like return on assets and low debt for selecting stocks and believes Chinese investor confidence will return, boosting the markets. Mobius prefers individual stocks over indexes, especially in China and Hong Kong, despite their recent downturns. U.S.-listed Chinese stocks like Alibaba, JD.com, Baidu, and Tencent have been affected by regulatory pressures and market conditions, as have ETFs like the iShares MSCI China A ETF and iShares MSCI Hong Kong ETF.

Portfolio Pulse from Shanthi Rexaline

February 14, 2024 | 8:45 am

VZ

Verizon Communications Inc. (VZ) has initiated five separate tender offers for its outstanding debt securities, aiming to purchase up to €1.5 billion in aggregate principal amount. These offers are detailed in the Offer to Purchase document dated February 14, 2024.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 8:35 am

LDTC

LeddarTech Holdings Inc. (NASDAQ:LDTC), an automotive software company, announced adjustments to the exercise price of its outstanding warrants expiring December 21, 2028. The new exercise price is set at $11.17 per share, down from $11.50. These adjustments, effective as of February 9, 2024, also extend to the redemption provisions of the warrants.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 7:45 am

NAMS

NewAmsterdam Pharma has announced the pricing of its underwritten public offering, which includes over 4.48 million ordinary shares at $19.00 each and pre-funded warrants for approximately 4.74 million ordinary shares at $18.9999 each. The offering aims to raise a total of $175.3 million.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 7:40 am

IMNM

Immunome has announced a public offering of 10 million shares at $20 each, expecting to raise $200 million before expenses. The underwriters have an option to buy an additional 1.5 million shares. The offering is set to close on February 16, 2024, pending customary closing conditions.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 7:38 am

OMH

Ohmyhome has announced an upsized public offering of 555,555 ordinary shares priced at $1.35 per share, raising a total of $4.8 million. This move is aimed at increasing the company's capital for future investments and operational expenses.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 7:36 am